ADS-ADEA 2016* , ,
Presentations this author is a contributor to:
The 5:2 STOP Study: A pilot study to compare the metabolic effects and safety of weight loss via intermittent fasting versus standard continuous energy restriction in patients with Type 1 diabetes and overweight or obesity (#179)
11:45 AM
Jane Overland
ADS Clinical Orals - Obesity & Diabetes
Intermittent Fasting: appears an effective and safe strategy for weight loss and metabolic control in Type 2 Diabetes (#241)
2:00 PM
Charmaine Griffiths
ADS Clinical Poster Session - Nutrition